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Abstract
In the adult mammalian auditory epithelium, the organ of Corti, loss of sensory hair cells results in permanent hearing loss.
The underlying cause for the lack of regenerative response is the depletion of otic progenitors in the cell pool of the sensory
epithelium. Here, we show that an increase in the sequence-specific methylation of the otic Sox2 enhancers NOP1 and
NOP2 is correlated with a reduced self-renewal potential in vivo and in vitro; additionally, the degree of methylation of NOP1
and NOP2 is correlated with the dedifferentiation potential of postmitotic supporting cells into otic stem cells. Thus, the
stemness the organ of Corti is related to the epigenetic status of the otic Sox2 enhancers. These observations validate the
continued exploration of treatment strategies for dedifferentiating or reprogramming of differentiated supporting cells into
progenitors to regenerate the damaged organ of Corti.
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Introduction
In the functionally mature mammalian organ of Corti (OC),
hair cell regeneration does not occur endogenously as it does in the
hair cell epithelia of other vertebrates by evolutionarily conserved
mechanisms such as morphallaxis or epimorphosis [1]. However,
the functionally immature postnatal OC harbors a latent
regenerative potential. This intrinsic regenerative potential is
indicated by the presence of multipotent stem cells that, when
isolated, can self-renew and differentiate into supporting and hair
cell lineages, as demonstrated by otic sphere formation assays [2–
6]. These stem cell-like properties have been ascribed to the
supporting cell population of the postnatal OC. This conclusion is
supported by the observation that when postnatal supporting cells
are purified by fluorescence-activated cell sorting using approaches
such as p27
Kip1-GFP transgenic mice [7], side population analysis
[8], selective surface markers on supporting cells [6] or Lgr5-GFP
transgenic mice [9], they acquire stem cell-like properties similar
to progenitor cells in the early embryonic OC. The present report
focuses on otic spheres and stem cells derived from the postnatal
OC, herein referred to as organ of Corti derived stem cells
(OCSCs). A loss of OCSC isolation capacity and regenerative
potential of isolated supporting cells is seen after the second
postnatal week [4,7]. It is presumed that this loss is caused by a
depletion of endogenous stem/progenitor cells or by a loss of
intrinsic regenerative properties from the pool of supporting cells
in the sensory epithelium. Therefore, it is of particular interest to
understand how the postnatal presence of isolatable stem cells and
the loss of this capacity in the mature organ are controlled at the
molecular level.
The HMG-box transcription factor Sox2 functions with Oct4
and Nanog to maintain the pluripotency of embryonic stem cells
(ESCs) [10]. Remarkably, the forced expression of Sox2 in
combination with Oct4, cMyc and Klf4 induces the formation of
pluripotent stem cells (iPSCs) from differentiated somatic cells
[11]. In ESCs, Sox2 functions as a molecular rheostat because
tightly regulated Sox2 levels control the expression of critical
subsets of genes, thereby stimulating the opposing phenomena of
either self-renewal or differentiation [12]. A similar dual function
is seen in neural stem cells (NSCs); here, Sox2 is required to
maintain ‘‘stemness’’ [13], but it also controls the seemingly
opposed differentiation of distinct cell types in the eye [14] and
brain [15], which indicates that Sox2 has dose- and context-
dependent functions [16,17]. In the OC, Sox2 also appears to
serve a dual role in establishing progenitors in the prosensory
domain [18] and the subsequent differentiation of supporting cells
[19]. In the vestibular epithelium, Sox2 has also been described to
function in both sphere formation and differentiation of inner ear
stem cells derived from the utricle [20].
Numerous studies suggest that the complex regulation of Sox2
in ESCs, NSCs and potentially OCSCs is influenced by the
activity of Sox2 enhancer elements [21–26]. The Sox2 enhancers
SRR1 and SRR2 are known to exert their activities in ESCs
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that two enhancer elements, NOP1 and NOP2, (Figure S1A, B)
are uniquely activated in nasal and otic placodes during chicken
development [25]. The sequences of these functionally identified
otic Sox2 enhancers correspond to extragenic sequence blocks,
that are conserved in chickens (Chicken Sox2: GenBank:
AB092842.1), mice (Mouse chromosome 3 including Sox2:
GenBank: AL606746.17) and humans [25] (Human chromosome
3 including Sox2: GenBank: AC117415.7) (Table S1, Figure S1A,
B). Two mouse mutants, Ysb and Lcc (Figure S2A, B), represent
unique alleles of Sox2 in which complex chromosomal rearrange-
ments have resulted in the compromised function of specific
enhancers that direct Sox2 expression in the inner ear [18].
Findings in these mutants indicate a critical role for the tissue-
specific Sox2 enhancers in the establishment and maintenance of
otic progenitors in the sensory primordium during development
[18]. In fact NOP1 enhancer activity has been directly demon-
strated in the otic placode of a primary transgenic mouse model at
embryonic day (E) 9.5 (Kondoh H, pers. communication). In
summary, these findings suggest a putative role for the NOP1 and
NOP2 enhancers in regulating the stemness of the OC.
In this study, the molecular signature of OCSCs, NSCs and
ESCs revealed similarities between the OCSCs and the NSCs,
with the exception of the SRR1/SRR2 and NOP1/NOP2
enhancer status. During OC development, the Sox2 promoter
remained demethylated, whereas the otic enhancers NOP1 and
NOP2 were subject to progressive methylation. The OCSCs
maintained an otic Sox2 enhancer methylation pattern that
resembled differentiating postnatal supporting cells. A pro-
nounced, sequence-specific methylation of NOP1 and NOP2
enhancers was observed in relation to differentiation in vivo and in
vitro. In addition, NOP1 and NOP2 enhancer methylation in
OCSCs was induced by EGF stimulation and predominately
resulted in a previously characterized non-self-renewing hollow
otic sphere phenotype [27]. Overall the epigenetic status of the
otic Sox2 enhancers NOP1 and NOP2 reflected the stemness of
the embryonic and early postnatal OC and OCSCs.
Results
OCSCs resemble a multipotent NSC state rather than a
pluripotent ESC state
To define the molecular signature of OCSCs, the DNA
methylation pattern within the promoter regions of the three key
pluripotency genes (Sox2, Oct4 and Nanog) was analyzed applying
a quantitative methylation approach using bisulfite conversion and
quantitative methylation analysis (EpiTyper).
Previous studies have shown that OCSCs isolated from the OC
can self-renew and differentiate into supporting and hair cell-like
cells, which is consistent with a multipotent stem cell state
[4,6,27,28]. For a comparative classification, we also analyzed
multipotent NSCs from the postnatal forebrain and pluripotent
ESCs from the same genetic background. The Sox2 promoter was
highly demethylated in all three stem cell populations (ESCs 7%;
NSCs 6%; OCSCs 10%) (Figure 1A). The Nanog and Oct4
promoters were also demethylated in ESCs (12% and 11%,
respectively), whereas the same promoters were methylated in
NSCs (54% and 50%, respectively) and OCSCs (35% and 58%,
respectively) (Figure 1A). Overall cluster analysis of all three
promoters demonstrated that OCSCs and NSCs featured a similar
epigenetic pattern, that differed from that observed in ESCs
(Figure 1A). However, differences in the tissue-specific epigenetic
landscape of OCSCs and ESCs/NSCs were evident in our analysis
of the ESC- and NSC-specific Sox2 enhancers SRR1 and SRR2
[22,24]. A cluster analysis of SRR1 and SRR2 confirmed a similar
demethylated pattern for ESCs (5% and 8%, respectively) and
NSCs (6% and 4%, respectively), whereas the same enhancers
were methylated in OCSCs (45% and 37%, respectively)
(Figure 1B). Transcripts for the pluripotency-related genes Sox2,
Nanog, Oct4, Klf4 and cMyc were determined in ESC, NSC and
OCSC preparations using Reverse Transcription Polymerase
Chain Reaction (RT-PCR). All pluripotency-related mRNAs were
expressed in all three stem cell populations, except Oct4, which
was not detected in OCSCs and NSCs (Figure 1C).
OCSCs, NSCs and ESCs were further compared at the
transcriptional level using quantitative PCR (qPCR) (Figure 1D,
Table S2A). The data were normalized to positive-control ESCs
that expressed all five ESC marker genes (i.e., Sox2, Nanog, Oct4,
cMyc and Klf4). We determined that Nanog and Oct4 were
silenced in OCSCs (0.018-fold and 0.004-fold, respectively) and
NSCs (0.004-fold and 0.001-fold, respectively), whereas Sox2,
cMyc and Klf4 were expressed in both stem cell populations
(Table S2A). Overall, a cluster analysis of all pluripotency-related
genes demonstrated a transcriptional pattern that was similar for
OCSCs and NSCs but differed from that of ESCs (Figure 1D).
At the protein level, immunocytochemical labeling of Sox2,
Nanog, Oct4, cMyc and Klf4 demonstrated nuclear expression of
Sox2 and Klf4 in all three stem cell populations; however, Nanog,
Oct4 and cMyc expression was confirmed only in ESCs
(Figure 1E).
Otic Sox2 enhancers are subject of epigenetic regulation
during OC development
The comparative analyses of the three different stem cell types
raised the question to what extent the developmental decrease in
OCSC isolation capacity [4] and the related decrease in stemness
[7] relates to Sox2 and its epigenetic transcriptional regulation.
Hence, the developmental pattern of Sox2 protein expression
was analyzed to identify Sox2 in the following three types of cells:
embryonic proliferating otic progenitors, postnatal maturing
supporting cells and fully differentiated supporting cells at the
functionally mature stage. At E13.5, nuclear Sox2 expression was
co-localized with the proliferation marker Ki-67, indicating the
presence of Sox2-positive proliferating progenitors in the prosen-
sory domain of the proximal cochlear duct (Figure 2A). At
postnatal day 4 (P4), in the maturing OC, nuclear Sox2 expression
was co-localized with the cell cycle inhibitor p27
Kip1 in postmitotic
supporting cells (inner phalangeal cells, pillar cells, Deiters’ cells,
Hensen’s cells) (Figure 2B). This pattern of Sox2 expression and
co-localization with p27
Kip1 was maintained in the supporting cells
of the functionally mature epithelium at P21, which is devoid of
any stem cell isolation capacity [4] or regenerative potential in its
supporting cells at P14 [7]. At postnatal day 4 weak expression of
p16
Ink4a was detectable in a subset of Sox2-positive supporting
cells (Figure S5B). At the functionally mature P21 stage, all of the
different supporting cell types of the OC showed co-localization of
Sox2 with the senescence marker p16
Ink4a (Figure 2C) indicating
terminal differentiation and replicative senescence [29] of
supporting cells at this time point. These findings demonstrate
that Sox2 expression is maintained during three different states of
the cell cycle in cochlear supporting cells at three different
developmental time points.
To explore the function of Sox2 in stemness and differentiation,
a comparative characterization of Sox2 expression during OC
development was performed. Eight additional genes were assessed
in parallel. The pluripotency-associated factors cMyc, Nanog, Klf4
and Oct4 were analyzed and considered indicative of stemness
[30]. Hair cell differentiation was represented by the transcription
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differentiation was indicated by expression of the cell cycle
regulator p27
Kip1 [34] and Prox1 [35]. RT-PCR confirmed the
transcription of all stemness- and differentiation-related genes,
except Oct4, during OC development (Figure 2D).
To quantify differential gene expression, the relative abundance
per single gene transcript was evaluated at the three developmen-
tal time points (i.e., E13.5, P4, P21) using qPCR. Based on the
relative developmentally induced changes, transcripts were classi-
fied into three groups of developmentally regulated genes (early,
transition, differentiation genes) as previously described in a
different context [36] (see Figure S3, Table S2B and Supplemental
Experimental Procedures S1). To facilitate the comparative
analysis, data were normalized to the E13.5 progenitor stage.
Each developmental stage was represented by a distinct expression
pattern of the analyzed genes (Figure 2E). The proliferating
primordium (E13.5) was characterized by a basal level of transition
genes, such as Sox2 and Atoh1, a high level of the early gene cMyc
and low levels of the differentiation genes Prox1 and p27
Kip1. The
postmitotic maturing OC (P4) showed a 3.9-fold (p,0.01) increase
in the level of the transition gene Sox2 and maximum expression
of the antagonistic factor Atoh1 (Figure 2E, Table S2B). In the
functionally mature epithelium (P21), Sox2 was down-regulated
(p,0.01), as compared to P4, back to the basal level observed at
E13.5. At P21 the differentiation genes p27
Kip1 and Prox1 reached
maximum levels, while the early gene cMyc dropped to its lowest
level (Figure 2E, Table S2B). Nanog and Oct4 were classified as
low copy number or background genes (Figure S3D), and Klf4 was
Figure 1. Comparative analysis of the pluripotency factors Sox2, Nanog, Oct4, cMyc and Klf4 in ESCs, NSCs and OCSCs. (A) Bisulfite
methylation profiles for Sox2, Nanog and Oct4 promoters in ESCs, NSCs and OCSCs. (B) Bisulfite methylation profiles for the Sox2 enhancers SRR1 and
SRR2 in ESCs, NSCs and OCSCs. DNA methylation values are depicted on a pseudo-color scale as indicated (methylation increases from red [non-
methylated] to yellow [methylated]); missing values are shown in grey. (C) RT-PCR analysis of pluripotency marker expression in ESCs, NSCs and
OCSCs. Ubiquitin C was used as the loading control. (D) qPCR analysis for the same five factors as in (C) in ESCs, NSCs and OCSCs. DCT values were
normalized to HPRT1/TbP, compared using a Pearson’s Correlation and displayed in a heat map. Red indicates up-regulation with a DCT value below
the mean level the analyzed dataset, and green indicates down-regulation with a DCT value above the mean level (i.e., see also Figure S3, Table S2A).
(E) Immunocytochemistry of ESCs, NSCs and OCSCs. Identical settings were used for image acquisition (Scale Bar: 10 mm).
doi:10.1371/journal.pone.0036066.g001
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e36066Figure 2. Epigenetic, transcriptional and translational characterization of Sox2 expression during OC development. (A–C) OC during
development. (A) Upper panel: Schematic of the sensory domain, which contains the proximal cochlea duct, showing interkinetic nuclear migration
at E13.5. Sox2 expression is indicated by red nuclei. Remaining panels: marker expression at E13.5. All proliferating Ki-67-positive cells are co-labeled
for Sox2. (B) Upper panel: schematic of the different cell types found in the maturating OC at P4. Inner hair cell (ihc, arrowhead), three outer hair cells
(ohc, arrowheads) and different supporting cells: inner sulcus cells (is); interphalangeal cells (i); pillar cells (p); Deiters’ cells (d); Hensen’s cells (h); and
Claudius cells (c). Remaining panels: marker expression at P4. The quiescence of Sox2-positive supporting cells is indicated by co-labeling with
p27Kip1. (C) Upper panel: schematic of the different cell types found in the functional OC at P21. Remaining panels: marker expression at P21.
Senescence of Sox2-positive cells is indicated by p16Ink4a expression. (D) RT-PCR of pluripotency marker, hair cell marker and supporting cell marker
expression in the OC (E13.5, P4, P21). HPRT1 was used as the loading control. (E) qPCR analysis of six developmentally regulated genes (cMyc, Sox2,
Atoh1, Myosin VIIa, p27Kip1 and Prox1) during OC development (E13.5, P4 and P21). The relative expression levels of P4 and P21 were compared with
those at E13.5. The transcript levels were normalized to HPRT1/Ubiquitin C levels. Averages of the three independent experiments with SDs are
Stemness of the Organ of Corti
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36066classified as a non-differentially regulated gene. Consequently,
Nanog, Oct4 and Klf4 were not assigned to any of the investigated
groups (Table S2B). These results indicate that Sox2 expression is
developmentally regulated and carefully titrated. A 4-fold tran-
scriptional up-regulation (Figure 2E) was correlated with the
transition from proliferating progenitors at E13.5 to differentiat-
ing, quiescent supporting cells at P4 (Figure 2A, B). However, at
P21 in the functionally mature organ Sox2 nuclear protein
expression was maintained (Figure 2C), but a significant down-
regulation occurred at the transcriptional level (Figure 2E).
To investigate the epigenetic mechanisms that might control
Sox2 expression levels, the CpG methylation status of the Sox2
promoter was compared to that of the Nanog and Oct4 promoters
during OC development. CpG islands within the Sox2 promoter
remained demethylated at all three investigated time points
(E13.5, 4%; P4, 7%; P21, 8%) (Figure S4A), which enabled
constitutively active Sox2 transcription. Over the same time
course, increased promoter silencing was seen for Nanog (E13.5,
15%; P4, 34%; P21, 46%) and Oct4 (E13.5, 28%; P4, 42%; P21,
57%) (Figure S4A). In contrast to the Sox2 promoter, the otic Sox2
enhancer elements NOP1 and NOP2 [25] showed a moderate
increase in methylation during the early phase of OC develop-
ment. This increase resulted in a clustering of E13.5 (NOP1, 12%;
NOP2, 11%) with P4 (NOP1, 24%; NOP2, 24%), whereas
progressive methylation was found for the mature P21 develop-
ment stage (NOP1, 37%; NOP2, 39%) (Figure 2F). The further
increase in NOP1 and NOP2 methylation from P4 to P21
correlated with the down-regulation of Sox2 mRNA to basal levels
(Figure 2E). Interestingly, the SRR1 and SRR2 enhancers, which
are supposedly not involved in otic development, follow a different
time course of methylation during OC development (Figure 2G),
resulting in a clustering of the P4 methylation pattern with the
pattern at P21 (E13.5: SRR1, 10%; SRR2, 10%; P4: SRR1, 32%;
SRR2, 17%; P21: SRR1, 36%; SRR2, 16%). In summary, the
demethylated status of the Sox2 promoter enables for constitutive
Sox2 expression in otic supporting cells, whereas modifications in
the methylation of the otic enhancer elements might contribute to
the fine titration of the Sox2 expression levels during development.
Promoter and regulatory elements in general are known to serve
as integration sites of upstream signaling. Here, a sequence
analysis of the NOP1 and NOP2 enhancer elements identified
numerous DNA-binding motifs (Figure S1A, B). Because three
potential SOX/LEF factor-binding sites [37] occur in the NOP1
and NOP2 sequences, it is possible that those enhancers are
activated by Sox2 (Figure S1A, B). Additional binding sites in both
enhancers include dEF1/SIP1 motifs [38] that overlap with E2
motifs, homeodomain protein binding sites and E-box motifs
(Figure S1A, B); however, the significance of these predicted
binding sites remains to be examined.
Generation of multipotent otospheres does not affect
the methylation status of Sox2 enhancers
Because Sox2 is thought to function in a dose-dependent
manner, the methylation status of its enhancers may contribute to
the regulation of Sox2 expression. A combination of dose- and
context-dependent Sox2 functions may contribute to the develop-
mental changes in the sphere isolation capacity of the OC. To test
this hypothesis, we investigated whether the Sox2 enhancer is
subject to epigenetic modification during the generation of OCSCs
in an otic sphere assay.
OCSCs exhibited no significant change in the methylation of
the activated Sox2 promoter when compared with the P4 stage
cells from which the otic spheres were isolated (Figure S4A). The
methylation patterns of the silenced Nanog and Oct4 promoters
also remained unaffected by the otic sphere formation procedure
(Figure S4A). Furthermore, the CpG methylation pattern of the
otic placode-related Sox2 enhancers NOP1 and NOP2 remained
stable after otic sphere formation (P4: NOP1, 24%; NOP2, 23%;
OCSC: NOP1, 25%; NOP2, 29%) (Figure 3A). Accordingly,
cluster analysis revealed that no reprogramming of NOP1 or
NOP2 was induced by otic sphere formation (Figure 3A). In
addition, the methylation pattern of the ESC- and NSC-related
Sox2 enhancer elements SRR1 and SRR2 remained unchanged
(Figure 3B).
Sox2 mRNA expression was assessed using qPCR to determine
whether otic sphere formation was accompanied by relative
changes in Sox2 mRNA expression. To facilitate the comparative
analysis, the data were normalized to the P4 developmental stage
from which the OCSCs were isolated; this normalization allowed
for a direct comparison of the OCSCs and the developmental
progenitor stage at E13.5.
The OCSCs demonstrated a significant down-regulation of the
transition gene Sox2 (p,0.01, Table S2C) as compared to P4,
reaching levels similar to those at the proliferating progenitor stage
at E13.5. This response correlated with a significant up-regulation
of the early gene cMyc (p,0.01, Table S2C) and a concomitant,
significant down-regulation of genes indicative of hair cell and
supporting cell differentiation (p,0.01, Figure 3C, Table S2C).
To further explore and verify this transcriptional dedifferenti-
ation response at the translational level, an immunohistochemical
analysis was performed for Sox2 and other stemness markers. A
comprehensive set of markers was analyzed at the three
representative developmental time points (E13.5, P4 and P21) to
distinguish Sox2-positive, proliferating otic progenitor cells (E13.5)
from Sox2-positive, postmitotic supporting cells (P4 and P21).
The Sox2-positive progenitors (Figure 2A and 4A) differed in
various aspects from quiescent (P4) (Figure 2B and 4B) and
terminally differentiated (P21) Sox2-positive supporting cells
(Figure 2C and S5A). First, co-localization of Sox2 with the
proliferation markers Ki-67 (Figure 2A) or PCNA (Figure 4A) was
only detected during the progenitor stage at E13.5 but never
during the postnatal stages at P4 (Figure 4B and S5B) and P21
(Figure S5A). Second, when the expression of the adult stem cell
markers Bmi1 [39] and Hmga2 [40], which are transcription
factors known to antagonize p16
Ink4a-mediated replicative senes-
cence in NSC populations [29], was monitored during the OC
development, an inverse relationship between p16
Ink4a and Bmi1
expression was observed. Pronounced Sox2/Bmi1 double labeling
was characteristic of the otic progenitor stage at E13.5 (Figure 4A),
but Bmi1 expression declined in the Sox2-expressing supporting
cell domain of the OC at P4 (Figure 4B). At the same time point,
an initial weak signal for p16
Ink4a was detected in a subset of Sox2-
positive supporting cells (Figure S5B). At P21, the functionally
mature stage, Sox2-positive supporting cells were completely
devoid of Bmi1 expression (Figure S5A) but showed a strong signal
for p16
Ink4a (Figure 2C). Hmga2 expression was found at all three
developmental stages (Figure S5A, B, C) and in the OCSCs
shown (*p,0.05) (i.e., see also Table S2B). Depending on the temporal expression pattern, genes were assigned to early, transition or differentiation
groups (i.e., see also Figure S3). (F,G) Bisulfite methylation of the Sox2 enhancers (f) (NOP1/2) and (g) (SRR1/2) during OC development (E13.5, P4,
P21) (i.e., see also Figure S4). (Scale Bars: A,B,C, 10 mm).
doi:10.1371/journal.pone.0036066.g002
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labeling the Notch ligand Jag1 and the Notch mediator Hes1.
Both factors were strongly expressed in Sox2-positive progenitors
at E13.5 (Figure 4A) but they became down-regulated as
development proceeded; however, weak staining was maintained
through P4 (Figure 4B) and P21 (Figure S5A).
The quiescent OC developmental stage at P4 gave rise to otic
spheres with proliferating Sox2-positive cells, as shown by the co-
localization of Sox2 with Ki-67 (Figure S5D) and PCNA
(Figure 4C). In addition, 2-hour pulse-labeling of otic spheres
with EdU indicated that 39628% (n=3, 12 spheres in total) of
Sox2-positive cells were in S-phase, a sign of active proliferation
(Figure S5D). In otic spheres, Sox2-positive cells also demonstrated
double labeling with the stemness-related gene Bmi1 (Figure 4C)
similar to E13.5 (Figure 4A). Furthermore, the Notch signaling
markers Jag1 and Hes1 were labeled in otic spheres (Figure 4C)
similar to the progenitor stage at E13.5 (Figure 4A). Taken
together, dissecting the OC and applying defined in vitro culture
conditions induced sphere formation. Sphere isolation itself had no
effect on the epigenetic regulation of Sox2 in terms of a
reprogramming response. However, the same assay accounted
for a dedifferentiation response in the otic spheres, which became
evident by the transcriptional regulation of Sox2 itself together
with the mRNA and protein regulation of proliferation markers,
stemness and Notch signaling markers in Sox2 positive cells.
Otosphere differentiation is correlated with sequence-
specific methylation of the enhancers NOP1 and NOP2
To confirm that the progressive developmental methylation of
the enhancers NOP1 and NOP2 and the concomitant loss of
cellular plasticity as seen in the fully differentiated OC at P21 was
related to progressive differentiation, the experimental setup was
inverted by applying differentiation-inducing culture conditions to
the OCSCs after their formation. When dedifferentiated oto-
spheres were transferred from suspension to adherent culture
conditions, including growth factor withdrawal, the otospheres
formed E-cadherin-positive, differentiating epithelial islands (Fig-
ure S6A). To evaluate the general differentiation potential of these
epithelial islands, we analyzed the epigenetic, transcriptional and
translational regulation of Sox2 expression in the context of other
developmentally regulated genes. To compare in vivo and in vitro
differentiation conditions, the OCSC stage after five days in vitro
culture (5 DIV) served as the starting point. The fully differentiated
OC at P21 in vivo was compared to epithelial island under
differentiating culture conditions after 28 DIV roughly corre-
sponding to the developmental time stretch from E13.5 to P21.
Figure 3. Epigenetic and transcriptional characterization of Sox2 during OCSC isolation. (A,B,C) Methylation profile of the Sox2
enhancers (A) SRR1/2, (B) NOP1 and (C) NOP2 in OCSCs as compared to the OC at P4 and E13.5 (i.e., see also Figure S4). (D) qPCR analysis of six
developmentally regulated genes (cMyc, Sox2, Atoh1, myosin (Myo) VIIa, p27Kip1 and Prox1) in OCSCs and the OC at E13.5 and P4. Relative
expression levels of OCSCs and E13.5 OC were compared with those of P4 OC. Transcript levels were normalized to HPRT1/Ubiquitin C levels.
Averages of three independent experiments with SDs are depicted (*p,0.05) (i.e., see also Table S2C).
doi:10.1371/journal.pone.0036066.g003
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remained constitutively active in the epithelial islands after 28 DIV
(Figure S4A). However, the Sox2 enhancers NOP1 and NOP2
became silenced (NOP1, 56%; NOP2, 72%) (Figure 5A). The
Oct4 and Nanog promoters remained silenced during in vitro and
in vivo differentiation (Figure S4A).
Transcriptional aspects of differentiation in the epithelial islands
were analyzed by qPCR after 14 and 28 DIV in differentiation
Figure 4. Characterization of Sox2 translation during OCSC isolation. (A,B) Double-labeling of Sox2 with PCNA, Bmi1, Jag1 and Hes1 in the
OC at E13.5 and P4 compared to OCSCs. (A) Representative immunostaining images of longitudinal cryosections of the prosensory domain in the
proximal cochlea duct at E13.5 (basilar membrane on top, luminal surface on the bottom). (B) Immature (P4) OC in mid-modiolar sections of the basal
cochlea turn (medial to the left). (C) P4 OC-derived otic spheres after 5 DIV. Due to the requirements for the different tissue types investigated, the
fixation, staining protocols and image acquisition settings were not identical (Scale Bars: A,B,C, 10 mm) (i.e., see also Figure S5).
doi:10.1371/journal.pone.0036066.g004
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DIV).
Although Sox2 has been classified as a transition gene during
development (Figure 2E), Sox2 expression levels significantly
declined (p,0.01) in the epithelial patches after 14 DIV but
returned to OCSC levels at 28 DIV (Figure 5B, Table S2D).
To completely characterize the differentiation potential of
OCSCs, we analyzed protein expression in epithelial patches at
Figure 5. Differentiation potential of OCSCs. (A,B) Methylation profiles of the otic Sox2 enhancers (A) NOP1 and (B) NOP2 in the mature OC
(P21), proliferating OCSC spheres and epithelial patches differentiated from OCSC spheres (i.e., see also Figure S4). (C) Relative expression levels of six
developmentally regulated genes (cMyc, Sox2, Atoh1, myosin (Myo) VIIa, p27Kip1 and Prox1) after 14 and 28 days of differentiation (n=3) were
compared with those of the proliferating OCSC spheres by qPCR. Transcript levels were normalized to TbP/Ubiquitin C levels. Shown are averages of
three independent experiments (and two independent experiments for 28 days for the differentiation group) with SDs (*p,0.05) (i.e., see also Table
S2D). (D–G) In situ cell type-specific marker expression of the maturing OC (P4): Sox2 antibody (F) labels all supporting cells of the sensory domain
(G), whereas S100-antibody (D) detects pillar and Deiters’ cells only (G). Myosin VIIa (E) expression is associated with inner and outer hair cells (G).
(H–K) OCSC-derived progeny differentiated under in vitro culture conditions. OCSC progeny were labeled by an EdU pulse (during the last day of 5
DIV) under proliferative culture conditions and a pulse chase after 14 DIV under differentiation-inducing culture conditions. EdU-labeling in
supporting cell (Sox2, S100) (H) and hair cell-like (myosin VIIa) (I) cells. Hair cell-like cells were additionally characterized based on membrane-
localized prestin (J) and F-actin-stained (K) membrane protrusions (Scale Bars: D,E,F,H,I,J,K, 10 mm) (i.e., see also Figure S6).
doi:10.1371/journal.pone.0036066.g005
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compared the patterns to the corresponding P4 developmental
time point. At P4, myosin VIIa is a marker of early hair cell
differentiation (Figure 5D), whereas Sox2 (Figure 5E) and S100
(Figure 5C) are expressed in a subset of cochlear supporting cells
(Pillar and Deiters’ cells) (Figure 5F). A 24-hour pulse of EdU at
the end of the otic sphere culture period stably labeled the progeny
of proliferating OCSCs. The fates of these EdU-labeled cells were
tracked after 14 DIV in differentiating culture conditions. Some
EdU-labeled cells differentiated into supporting and hair cell
lineages. Newly generated Pillar- and Deiters’ cell-like cells were
indicated by the co-localization of EdU, Sox2 and S100
(Figure 5G). Hair cell-like cells were tracked by the co-localization
of EdU and myosin VIIa (Figure 5H). Similar to the native OC
(Figure 5F), organ-like cell clusters were detected. Myosin VIIa-
positive hair cell-like cells appeared in close proximity to the Sox2-
positive supporting cell-like cells (Figure 5I). Ongoing hair cell
differentiation was further indicated by labeling with additional
hair cell markers including myosin VI, parvalbumin and calretinin
(Figure S6B). This hair cell differentiation progressed to the
advanced stages, as indicated by labeling of the outer hair cell
(OHC) marker protein prestin [41] (Figure 5I). At the subcellular
level, expression of the membrane-bound protein prestin implies a
progression of in vitro differentiation to the level of functional hair
cells, which are normally found at the late developmental stage
P12 [41]. This notion was further supported by the appearance of
F-actin-positive stereocilia-like protrusions (Figure 5J) at the apical
pole of the hair cell-like cells.
EGF induces the sequence-specific methylation of NOP1
and NOP2 enhancers in parallel with a hollow sphere
phenotype
The increased methylation of NOP1 and NOP2 observed under
differentiating culture conditions parallels the in vivo situation,
raising the question of whether the experimental conditions can
also be modified to promote the methylation of NOP1 and NOP2
under primary sphere forming conditions resulting in a concom-
itant loss of the stemness assigned to OCSCs. The observed
dedifferentiation response to generate OCSCs required a specific
combination of cell culture medium, supplements and growth
factors. Systematic variation in the composition of the growth
medium was used to assess otic sphere formation capacity. Since
the self-renewal potential of the total otic sphere population has
previously been ascribed to the solid fraction of otic spheres [27],
appearance of different sphere phenotypes has been investigated.
The standard growth factor combination used in this investigation
consisted of FGFb (10 ng/ml), IGF1 (50 ng/ml) and heparin
sulfate (HS) (2 mg/ml) (Figure 6A). The addition of a third factor,
EGF (20 ng/ml) (Figure 6B), resulted in a significant decrease in
the primary solid sphere fraction (Figure 6C), which was measured
using a diameter range of 25 to 60 mm using objective, automated
sphere counting. Under FGF/IGF-only culture conditions, a
single OC gave rise to approximately 16066810 otic spheres
(Figure 6C) with a mean diameter of 34.261.4 mm (Figure 6D)
(independent experiments: n=8). Addition of EGF significantly
reduced the number of otic spheres to 7906472 (p,0.05)
(Figure 6C), whereas the mean diameter of the measured sphere
population increased significantly to 38.161.9 mm (p=0.001)
(Figure 6D) (independent experiments: n=7). The EGF induced
increase in sphere diameter was accompanied by a sphere volume
gain of about 38%. Morphological analysis revealed the EGF-
dependent increase in volume as indicative for the switch from the
solid/self-renewing to the hollow/non-self-renewing phenotype
(Figure 6A,B). We thus sought to determine whether EGF
signaling interferes with the epigenetic regulation of NOP1 and
NOP2 in OCSCs.
The CpG methylation patterns of the Sox2 promoter and otic
enhancers were analyzed with EGF as an additional growth factor;
these patterns were compared to those in the FGF/IGF-only
conditions and to the developmental data. EGF supplementation
had no effect on the methylation of the Sox2, Nanog and Oct4
promoters (Figure S4A); however, methylation of the otic
enhancers NOP1 and NOP2 increased in EGF-treated spheres
as compared to OCSCs grown without EGF (NOP1: non-EGF,
24%; EGF, 36%; NOP2: non-EGF, 29%; EGF, 49%) (Figure 6E).
Surprisingly, under EGF conditions, the NOP1 and NOP2
enhancer methylation status did not resemble that of the
progenitor stage at E13.5 or of the otic sphere under FGF/IGF-
only conditions but instead clustered with that of the functionally
mature OC (P21). Therefore, the methylation pattern of NOP1
and NOP2 under EGF conditions was similar to the pattern
observed in the functionally mature OC under in vivo conditions.
Additionally, the assessed mRNA profiles differed from those
observed in otic spheres grown with FGF/IGF alone. The relative
Sox2 mRNA expression level was also significantly reduced
(p,0.01) as compared with its basal expression level in OCSCs
grown under FGF/IGF-only conditions (Figure 6F, Table S2E).
These results suggest that non-cell-autonomous factors like EGF
supplementation induce NOP1- and NOP2-specific methylation
under otic sphere-formation conditions, causing a concomitant
down-regulation of Sox2 expression. The conversion of the otic
sphere phenotype from a solid, self-renewing type under non-EGF
conditions to a hollow, non-self-renewing type under EGF-
treatment starkly supports the interconnection between NOP1
and NOP2 methylation and a loss of stemness.
Discussion
The findings presented in this study indicate that a low or
moderate methylation status of the tissue-specific Sox2 enhancers
NOP1 and NOP2 was correlated with a permissive role of Sox2
with regards to otic stemness, as seen in OCSCs and embryonic
progenitors or stem cell isolation potential as seen in postnatal
supporting cells. In contrast, progressive methylation was related
to supporting cell differentiation and loss of stemness both in vitro
and in vivo as well as in response to EGF treatment. Integration of
NOP1 and NOP2 methylation data into a comprehensive circular
map allowed visualization of these relationships showing the
association of the demethylated status with stemness above the y-
axis and the methylated status with a loss of stemness below the y-
axis (Figure 7A). This suggests that the methylation status of the
otic Sox2 enhancers NOP1 and NOP2 are inversely related to
conditions permissive to otic stemness (Figure 7B).
We generated OCSCs using an otic sphere forming assay and
then compared the molecular signatures of these OCSCs to those
of ESCs and NSCs. Specifically, levels of the three critical
transcription factors that establish the pluripotency network, Oct4,
Nanog and Sox2, were measured [42]. Oct4 and Nanog were
down-regulated in OCSCs at the epigenetic, transcriptional and
translational level, which was also observed in multipotent NSCs
but not in ESCs. Similarly, in inner ear stem cells derived from the
utricle Sox2 expression is maintained, while Nanog and Oct4
transcription is down-regulated [43]. Therefore, OCSCs show no
pluripotent developmental potential at the molecular level.
However, in NSCs single factor reprogramming by Oct4 in
addition to endogenously expressed Sox2 is sufficient for acquiring
pluripotency [44]. Therefore, based on endogenous Sox2 expres-
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PLoS ONE | www.plosone.org 9 May 2012 | Volume 7 | Issue 5 | e36066Figure 6. EGF interferes with the epigenetic regulation of Sox2 expression and affects the self-renewal potential of OCSCs. (A,B)P 4
OC-derived otospheres after 5 DIV; labeling for Sox2 combined with EdU and DAPI (A) Otospheres grown under FGF/IGF-only conditions. (B)
Otospheres supplemented with EGF as an additional growth factor (Scale Bars: A,B, 100 mm). (C) Absolute numbers of primary spheres isolated per
OC with (n=7) and without EGF (n=8) supplementation. Data were analyzed by student’s t-test and are presented as means 6SDs. (D) Mean
diameter of the primary sphere population measured in a range from 25 to 60 mm with (n=7) and without EGF (n=8) supplementation. Data are
presented as means 6SDs. (E) Methylation profiles of the otic Sox2 enhancers NOP1/2 in P21 OC, proliferating OCSCs and OCSCs supplemented with
EGF (i.e., see also Figure S4). (F) qPCR analysis of six developmentally regulated genes (cMyc, Sox2, Atoh1, myosin VIIa, p27Kip and Prox1) in standard
OCSCs and in OCSCs supplemented with EGF. Relative expression levels of standard OCSCs were compared to those of OCSCs supplemented with
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reprogramming.
Similar to NSCs the expression pattern of Sox2 in OCSCs
suggests that Sox2 plays a key role in the observed multipotency of
OCSCs. As a differentiating feature, at the Sox2 enhancer level,
the increased methylation status for SRR1 and SRR2 in OCSCs is
distinct from that of NSCs and ESCs; this finding suggests that in
OCSCs Sox2 expression is controlled by the otic enhancers NOP1
and NOP2 [25]. A previous investigation of the evolutionally
conserved Sox2 enhancers SRR1 and SRR2 [45] in human NT2-
D1 cells revealed a cell fate-specific methylation pattern in the
regulatory element SRR2. A different role was found for SRR1,
indicating a correlation between methylation state and prolifera-
tive potential. Such a functional division was not evident in our
investigation of the otic enhancers NOP1 and NOP2, as their
methylation patterns appeared uniform. Since supporting cell
types are overrepresented in cochlear tissue and in vitro culture
preparations, the discussion of the results reported here relates to
supporting and stem/progenitor cell fates.
During embryonic development of the inner ear Sox2
expression is controlled by inner ear-selective enhancer elements
and represents a critical factor in establishing the prosensory
domain of the OC, as previously demonstrated in two allelic Sox2
mouse mutants, Lcc and Ysb [18]. Because neither the protein-
coding region nor the promoter of Sox2 was affected by these
mutations [18], these mutants directly indicate the key role of the
tissue-specific enhancer elements NOP1 and NOP2, previously
identified as enhancers in the avian inner ear [25], in regulating
Sox2 expression in the mammalian OC. Sequence analysis
reported in this study revealed that the evolutionarily conserved
avian NOP1 and NOP2 sequences map to the murine genomic
locus affected by the Lcc mutation. Although the two integration
sites of the Ysb mutants did not alter the wild-type NOP1 and
NOP2 sequences, the identified chromosomal rearrangement
might interfere [18]. These findings imply that the Lcc and Ysb
phenotypes are correlated with a compromise in function of the
murine NOP1 and NOP2 enhancer elements.
It has been suggested that Sox2 plays a dose-dependent role in
the inversely correlated phenomena of stemness and differentia-
tion [19]. Further evidence for a Sox2 rheostat-like function is
provided by the present study, which revealed that Sox2 mRNA
levels change during development. At the same time that Sox2
levels increase from embryonic (E13.5) to postnatal (P4) time
points, an auto-regulatory loop mediated by a Sox2 binding site in
EGF. Transcript levels were normalized to HPRT1/TbP levels. Averages of three independent experiments are shown with SDs (*p,0.05) (i.e., see also
Table S2E).
doi:10.1371/journal.pone.0036066.g006
Figure 7. Methylation patterns of the otic Sox2 enhancers NOP1 and NOP2 are differentially regulated with regard to stemness and
otic differentiation. (A,B) The complete NOP1/2 datasets were analyzed by a circular map to visualize the relationships between analyzed
elements with respect to the topology inherent in the data. NOP1 and NOP2 methylation levels of OC (E13.5, P4 and P21) as compared to OCSC,
OCSC+EGF and differentiating epithelial island (28 DIV). The map is similar to clustering, but the arrangement is circular rather than linear to
emphasize the periodicity of the angular positions and to allow comparisons across conditions and factors.
doi:10.1371/journal.pone.0036066.g007
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during early postnatal development. This relationship possibly
contributes to the maintenance of the supporting cell phenotype,
which would be consistent with the previously reported finding of
a reciprocal antagonistic relationship between Sox2 in the
differentiating supporting cells and Atoh1 in the differentiating
hair cells [19]. During late postnatal development, Sox2
transcriptional down-regulation is correlated with an increase in
NOP1 and NOP2 enhancer methylation in the functionally
mature OC at P21. Vice versa at the embryonic developmental stage
low Sox2 levels may be related to early Notch signaling. Indeed,
conditional gene targeting has previously identified Sox2 as a
target gene of the Notch ligand Jag1, which is strongly expressed in
the proliferating primordium before cell differentiation [46]. In the
inner ear, Notch signaling is mediated by the bHLH transcription
factor Hes1 [47]. The bHLH transcription factors are known to
interact with E-box motifs [48], which have been computationally
identified in the NOP1 and NOP2 sequences in our study. As the
bHLH transcription factors act as transcriptional repressors, the
binding of Hes1 to NOP1 and NOP2 could account for the
maintenance of Sox2 expression at the low basal level found in the
embryonic OC. Consistent with this hypothesis, Hes1 expression is
down-regulated in the nascent OC by E14.5 [47], when the cells
exit the cell cycle and undergo cell fate decisions towards hair cell
and supporting cell phenotypes. Therefore, the early Notch
signaling-induced transcriptional silencing of NOP1 and NOP2
may be released and result in an up-regulation of Sox2 expression,
thus contributing to the differentiation and maintenance of
supporting cells.
Our results did not reveal any sequence-specific demethylation
of the investigated promoters or Sox2 enhancer elements induced
by the otic sphere assay. Therefore, OCSC formation in the otic
sphere assay may reflect an in vitro dedifferentiation response of the
postmitotic supporting cells rather than a reprogramming of the
somatic cells into stem cells after tissue explantation and
dissociation [49].
Nevertheless, the observed regulation of methylation patterns in
the tissue-specific Sox2 enhancer elements NOP1 and NOP2
points to a key role for epigenetic mechanisms in determining the
regenerative potential of the OC. In this study, we demonstrated
that the NOP1 and NOP2 enhancers have a demethylated status
at the developmental stage of the otic progenitors at E13.5. The
progressive developmental methylation of both enhancers is
correlated with a loss of stem cell isolation capacity in the
functionally mature developmental stage.
The Sox2 enhancer methylation levels in otic cells appear to
depend on non-cell autonomous factors, as demonstrated by the
effect of exogenous EGF application. The observed interplay
between EGF signaling and a reduced phenotypic self-renewal
potential has also been shown for NSCs in the subventricular zone
(SVZ) [50]. In that study, infusion of EGF into the lateral ventricle
of mice led to the proliferation of EGFR-expressing neural
progenitor cells. However, the potential for proliferation and self-
renewal of NSCs from the EGF-infused SVZ was reduced as
compared with controls. Thus, our finding of an EGF-induced
hollow otic sphere phenotype with a reduced self-renewal potential
[27] and the reduced self-renewal potential of NSCs of the SVZ
[50] indicate that self-renewal potential in both multipotent stem
cell types is negatively regulated by EGF supplementation. In
addition, EGF has been also shown to induce differentiation of
cochlear hair cells from dividing progenitor cells from the
embryonic developmental stage E13.5 which were directly isolated
and plated as epithelial island without going through sphere
formation [51].
It has been previously reported that otic sphere formation is
related to a gain in developmental potential, with transcriptional
and translational changes that are indicative of dedifferentiation
[2,4]. The results of this study further support these findings for the
OC. Dedifferentiation as seen in otosphere formation evokes a
phenotypic switch and a transcriptional and translational conver-
sion from postmitotic supporting cells into proliferating primordi-
al-like cells by a dynamic regulation of the transcriptome.
Future hair cell regeneration strategies should consider
supporting cell reprogramming to render senescent supporting
cells responsive to dedifferentiation. To a limited extent, sponta-
neous dedifferentiation responses have been observed in the OC
after hair cell damage (e.g., reactivation of embryonic Notch
signaling) [52]. We speculate that the addition of small molecule-
based reprogramming or dedifferentiation factors to cochlear
supporting cells could be a reasonable strategy for reactivating the
cells’ endogenous regenerative potential, thereby allowing epi-
morphic hair cell regeneration.
Materials and Methods
Animals
All mice used in this study were C57/BL6 background (Charles
River Laboratories, Sulzfeld, Germany); breeding and mainte-
nance were performed in an in-house animal facility. The use of
animals for organ explantation and stem cell isolation was
reviewed and approved by the Committee for Animal Experi-
ments of the Regional Council (Regierungspra ¨sidium) of Tu ¨bin-
gen.
Inner ear dissection
Mice were used at embryonic day (E) 13.5 and postnatal days
(P) 4 and P21. Mice were then euthanized with CO2 and
decapitated. After removing the brain, the inner ear bony
labyrinth capsules were dissected from the skull base in Hank’s
buffered saline solution (HBSS). Fixation of the inner ear was
carried out by perfusion of the oval window, the round windows
and an additional hole in the apex of the cochlea with 4% PFA.
Only P21 inner ears were decalcified with 0.2 M EDTA in PBS
for 2 days before being sliced into cryosections. After incubation in
sucrose (30% in PBS), preparations were embedded in a Tissue-
TekH OCT
TM Compound (Sakura Finetek, Zoeterwoude, The
Netherlands) and stored at 280uC. Cryosectioning was performed
with a Microm cryostat (Microm Laborgera ¨te GmbH, Walldorf,
Germany).
Immunohistochemistry
After blocking with 1% BSA in 0.2% Triton PBS, cryosections
were incubated overnight at 4uC with primary antibodies (Table
S3). After washing with 0.2% Triton/PBS, primary antibodies
were detected using Alexa-conjugated secondary antibodies for
60 min at RT (Table S3). The sections were counterstained with
DAPI, Syto60 or Sytox Green (Molecular Probes–Invitrogen,
Darmstadt, Germany) and mounted with FluorSave
TM (Calbio-
chem-Merck, Darmstadt, Germany). The sections were analyzed
using a Zeiss 510 Meta confocal laser-scanning microscope (Zeiss,
Go ¨ttingen, Germany).
Cell culture
ESCs, NSCs and OCSCs were from a C57/BL6 mouse
background. Details and culture procedures, including otosphere
isolation and otic differentiation, are described in the Supplemen-
tal Experimental Procedures S1.
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(EpiTyper) and real-time PCR
Inner ear tissues and cultured cells from 24-well tissue culture
plates (Greiner 35/10) were isolated and immediately frozen in
liquid nitrogen prior to lysis for RNA or gDNA isolation. Details
are available in the Supplemental Experimental Procedures S1.
Chicken, human and mouse Sox2 sequence analysis
Sequences were analyzed with Genomatix DiAlign professional
Release 3.1.4 software (Genomatix Software GmbH, Munich,
Germany). DNA motifs were scanned using YEASTRACT-
DISCOVERER software (http://www.yeastract.com/cite.php).
Supporting Information
Figure S1 NOP1 and NOP2 nucleotide sequences. (a, b)
Nucleotide sequences of the otic enhancers NOP1 and NOP2 of
the chicken Sox2 locus and alignment with the corresponding
human and mouse sequences. Sequences are shaded where the
nucleotide residue is conserved in all species. CpG sites are
underlined, and putative binding sequences of various transcrip-
tion factors conserved among the animal species are shown in
boxes.
(TIF)
Figure S2 NOP1 and NOP2 are covered by the Lcc locus
and may potentially interfere with the Ysb locus. (a)
Ideogram of mouse chromosome 3 showing the putative Ysb and
Lcc rearrangement sites. Blue and green bars, transgenes at
insertion sites 1 and 2; red bar, putative inversion of Lcc (modified
from Dong et al., 2002). (b) Lcc and Ysb wild type loci. Sox2 coding
region (including promoter) and Sox2 enhancers NOP1/2 are
covered by the Lcc locus as determined by linkage analysis of
polymorphic microsatellite markers (modified from Dong et al.,
2002). Due to the relative proximity to Ysb integration sites 1/2
determined in the wild-type sequence, NOP1/2 might also
interfere with Ysb rearrangements (modified from Dong et al.,
2002).
(TIF)
Figure S3 Criteria used to assign developmentally
regulated genes to early, transition or differentiation
gene groups. (a) Early genes were primarily expressed in the
progenitor cell population at E13.5, with significant down-
regulation at P4. (b) Transition genes were expressed up to P4,
with significant down-regulation in the mature OC at P21. (c)
Differentiation genes were expressed at very low levels in
proliferating progenitors at E13.5, were significantly up-regulated
at P4 and were stably maintained in the functional epithelium at
P21. (d) The relative amount of each gene transcript was
determined by qPCR assay, and data were analyzed using the
DD CT method. Primer efficiencies for unknown and reference
genes were confirmed using standard curve experiments. The CT
value determines the cycle threshold when the fluorescence
reading surpassed a set baseline. Depending on the CT value,
genes were classified as high and low copy number genes. CT
values ,35 were classified as background.
(TIF)
Figure S4 DNA methylation patterns during otic devel-
opment in situ and in vitro. (a) Bisulfite methylation profiles
for Sox2, Nanog and Oct4 promoters in the OC at three
developmental time points (E13.5, P4, P21), OCSCs (OCSC),
EGF-treated OCSCs (OCSC+EGF) and differentiated epithelial
patches (28 DIV). DNA methylation values are shown on a
pseudo-color scale (methylation increases from red [non-methyl-
ated] to yellow [methylated]); missing values are shown in grey.
(TIF)
Figure S5 Characterization of Sox2 translation. (a–c)O C
in mid-modiolar sections of the basal cochlear turn (medial to the
left). (a) OC at P21; labeling for Sox2 combined with PCNA,
Bmi1, Jag1, Hes1, Ki-67 and Hmga2. (b) OC at P4; labeling for
Sox2 combined with p16Ink4a, Ki-67 and Hmga2. (c)O Ca t
E13.5; labeling for Sox2 combined with Hmga2. (d) P4 OC-
derived otospheres after 5 DIV; labeling for Sox2 combined with
EdU, Ki-67 and Hmga2 (Scale Bars: a, b, c, d;1 0mm).
(TIF)
Figure S6 Differentiation potential of OCSCs. (a, b)
OCSC-derived progeny differentiated under differentiating in vitro
culture conditions (14 DIV). (a) E-cadherin-positive epithelial
island containing supporting cell-like cells, labeled for S100 and
Sox2 (b) Epithelial island containing hair cell-like cell, triple-
labeled for parvalbumin, calretinin and myosin VI (Scale Bars: a,
b,1 0mm).
(TIF)
Table S1 NOP1 and NOP2 enhancers of the Sox2 gene
and their conservation across chickens, mice and
humans.
(TIF)
Table S2 qPCR data shown as DD CT values.
(XLS)
Table S3 Antibodies and fluorophores used in the
study.
(TIF)
Supplementary Experimental Procedures S1
(DOC)
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